- Home
- ACRV vs FOXX Comparison
ACRV vs FOXX Comparison
Compare ACRV & FOXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- FOXX
- Stock Information
- Founded
- ACRV 2018
- FOXX 2017
- Country
- ACRV United States
- FOXX United States
- Employees
- ACRV N/A
- FOXX N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- FOXX
- Sector
- ACRV Health Care
- FOXX
- Exchange
- ACRV Nasdaq
- FOXX Nasdaq
- Market Cap
- ACRV 40.4M
- FOXX 37.7M
- IPO Year
- ACRV 2022
- FOXX N/A
- Fundamental
- Price
- ACRV $1.34
- FOXX $4.82
- Analyst Decision
- ACRV Buy
- FOXX
- Analyst Count
- ACRV 7
- FOXX 0
- Target Price
- ACRV $17.60
- FOXX N/A
- AVG Volume (30 Days)
- ACRV 379.9K
- FOXX 6.2K
- Earning Date
- ACRV 08-12-2025
- FOXX 08-15-2025
- Dividend Yield
- ACRV N/A
- FOXX N/A
- EPS Growth
- ACRV N/A
- FOXX N/A
- EPS
- ACRV N/A
- FOXX N/A
- Revenue
- ACRV N/A
- FOXX $53,866,257.00
- Revenue This Year
- ACRV N/A
- FOXX N/A
- Revenue Next Year
- ACRV N/A
- FOXX N/A
- P/E Ratio
- ACRV N/A
- FOXX N/A
- Revenue Growth
- ACRV N/A
- FOXX 3899.98
- 52 Week Low
- ACRV $1.05
- FOXX $2.45
- 52 Week High
- ACRV $10.16
- FOXX $12.80
- Technical
- Relative Strength Index (RSI)
- ACRV 55.88
- FOXX N/A
- Support Level
- ACRV $1.15
- FOXX N/A
- Resistance Level
- ACRV $1.38
- FOXX N/A
- Average True Range (ATR)
- ACRV 0.09
- FOXX 0.00
- MACD
- ACRV 0.02
- FOXX 0.00
- Stochastic Oscillator
- ACRV 83.33
- FOXX 0.00
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About FOXX Foxx Development Holdings Inc. Common Stock
Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals.